Safety and Efficacy of Metformin Glycinate vs Metformin Hydrochloride on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Apr 2014
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COMET
- Sponsors Laboratorios Silanes
- 07 Jun 2017 Biomarkers information updated
- 19 Feb 2014 Planned End Date changed from 1 Feb 2014 to 1 Oct 2016, as per ClinicalTrials.gov record.
- 19 Feb 2014 Status changed from not yet recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.